Skip to main content
. 2020 Nov 5;3(6):1391–1421. doi: 10.1021/acsptsci.0c00137

Figure 13.

Figure 13

Ability of different t.o. doses of the two enantiomers of a potent and selective 5-HT2A receptor agonist (DOI) to lower and control IOP in conscious OHT cynomolgus eyes. Reproduced with permission from ref (7). Copyright 2018 Mary Ann Liebert Publishing Inc.